Boston Scientific Stock Rises on Sales Increase, Positive Management Outlook

A slowdown in medical procedures due to the COVID-19 pandemic caused a decline in first-quarter profits at medical device maker Boston Scientific (NYSE:BSX), but the company still managed a small sales gain, and management made encouraging comments about the future in its earnings call Wednesday. In response to the report and the commentary, shares rose almost 4%.